Five things for pharma marketers to know: Monday, June 1, 2020
Sanofi stops recruiting for hydroxychloroquine trials; CDC guidelines may drastically change the corporate office; Diabetes drug recalled due to cancer-causing contaminant.
Roundup
Five things for pharma marketers to know: Friday, May 29, 2020
Quest Diagnostics’ COVID-19 test granted emergency use; Novartis teams up with Massachusetts researchers to produce coronavirus vaccine; New York allows businesses to deny entry to people without masks.
Five things for pharma marketers to know: Thursday, May 28, 2020
Big pharmacies worked with pharma to promote opioids, lawsuit claims; European governments ban hydroxychloroquine in COVID-19 patients; AstraZeneca tests diabetes drug as COVID-19 treatment.
Five things for pharma marketers to know: Wednesday, May 27, 2020
Merck begins developing COVID-19 vaccine; Pharmacies expect higher demand for flu vaccines; Medicaid will have plans that limit insulin copays.
Five things for pharma marketers to know: Tuesday, May 26, 2020
Coronavirus vaccines may work more like the annual flu vaccine; Researchers warn of second wave in South, Midwest; Register for a free account to access the 2020 Agency 100 issue.
Five things for pharma marketers to know: Friday, May 22, 2020
U.S. to provide $1.2 billion for potential COVID-19 vaccine; CVS expands drive-thru testing locations; A quarter of Americans have little interest in taking a coronavirus vaccine.
Five things for pharma marketers to know: Thursday, May 21, 2020
One-day coronavirus cases reach daily record; CDC publishes guidelines for reopening; AstraZeneca, Merck prostate cancer treatment approved.
Five things for pharma marketers to know: Wednesday, May 20, 2020
J&J to end baby powder sales in U.S.; Trump threatens to permanently end WHO funding; Register for the MM&M Transform Pre-Conference webcast on Thursday.
Five things for pharma marketers to know: Tuesday, May 19, 2020
Moderna’s COVID-19 vaccine produced antibodies in small trial; CDC warned of measles outbreaks due to fall in vaccinations; New York City may begin reopening in June.
Five things for pharma marketers to know: Monday, May 18, 2020
UnitedHealth, Microsoft launch app to screen workers for COVID-19; Hologic test granted emergency use authorization; Oxford coronavirus vaccine will be priced fairly.
Five things for pharma marketers to know: Friday, May 15, 2020
NIH begins study of malaria drug in COVID-19 patients; Five regions in New York being phased reopening plan; Former vaccine expert says coronavirus vaccine will take longer than 18 months.
Five things for pharma marketers to know: Thursday, May 14, 2020
WHO says “vicious cycle” to occur if restrictions lifted too early; Bluebird BIO, BMS blood cancer cell therapy application refused by FDA; MM&M Convene COVID-19 takes place today.
Five things for pharma marketers to know: Wednesday, May 13, 2020
Moderna coronavirus vaccine fast-tracked; LabCorp expands availability of COVID-19 tests; Fauci says there might be more “suffering and death” if states reopen too soon.
Five things for pharma marketers to know: Tuesday, May 12, 2020
Abbott antibody test granted emergency use authorization; Twitter to warn users about misleading coronavirus tweets; CEO of Amazon, JP Morgan, Berkshire health venture to depart.
Five things for pharma marketers to know: Monday, May 11, 2020
Child vaccination falls due to pandemic; Abbott’s COVID-19 test likely to product accurate results; Register today for access to MM&M’s 2020 Agency 100 issue.
Want to read more?
Please login or register first to view this content.
